Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

A novel, topical formulation of esmolol, a cardio-selective beta-1 adrenergic blocker, may just have landed a spot in the diabetes treatment landscape, as it shows promise as treatment alternative for diabetic foot ulcers (DFUs).

Beta-blocker shows potential for diabetic foot ulcers

20 Oct 2022

Smartphones measure physical performance after lumbar spine surgery

Smartphone-based real-life activity data can be used to track physical performance in patients after lumbar spine surgery for degenerative lumbar disorders (DLD), according to a recent study.

Smartphones measure physical performance after lumbar spine surgery

Smoking during pregnancy ups hypertension risk in offspring

Children exposed to maternal smoking during pregnancy have higher systolic blood pressure (SBP) and are at a heightened risk of hypertension, a recent study has found.

Smoking during pregnancy ups hypertension risk in offspring

20 Oct 2022

Vitamin D deficiency tied to death risk in diabetic foot ulcer

In patients with diabetic foot ulcers (DFU), vitamin D deficiency appears to aggravate the risk of all-cause mortality, reports a recent China study.

Vitamin D deficiency tied to death risk in diabetic foot ulcer

Fish oil lipid emulsion of little neurodevelopmental benefit in ELBW infants

In infants born with extremely low birth weight (ELBW), parenteral nutrition supplement using a mixed lipid emulsion containing fish oil does not result in neurodevelopmental or behavioural benefits at preschool age, a new study has found.

Fish oil lipid emulsion of little neurodevelopmental benefit in ELBW infants

Pembrolizumab improves DFS in completely resected stage IB–IIIA NSCLC

Adjuvant pembrolizumab significantly improves disease-free survival (DFS) vs placebo in patients with completely resected, PD-L1–unselected, stage IB–IIIA non-small-cell lung cancer (NSCLC), a second interim analysis of the triple-blind phase III PEARLS/KEYNOTE-091 trial has shown.

Pembrolizumab improves DFS in completely resected stage IB–IIIA NSCLC

20 Oct 2022

Dupilumab reduces itch, improves skin lesions in prurigo nodularis

Dupilumab improves itch response and skin lesions in patients with prurigo nodularis (PN) inadequately controlled with prior therapies in the LIBERTY-PN PRIME trial.

Dupilumab reduces itch, improves skin lesions in prurigo nodularis

Add-on ozoralizumab safe, effective in rheumatoid arthritis

Ozoralizumab, when used in combination with methotrexate (MTX), appears to yield significant reductions in the signs and symptoms of rheumatoid arthritis (RA) while having an acceptable tolerability, according to data from a double-blind, parallel-group, placebo-controlled phase II/III trial.

Add-on ozoralizumab safe, effective in rheumatoid arthritis

Intravaginal laser therapy, hyaluronic acid suppositories help counter urogenital atrophy

19 Oct 2022 bởi

Breast cancer patients with urogenital atrophy may benefit from intravaginal laser therapy and hyaluronic acid suppositories, with a recent study showing that both help resolve related symptoms equally.

Intravaginal laser therapy, hyaluronic acid suppositories help counter urogenital atrophy

High egg intake poses no risk of cardiovascular events